Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $14.6M | $10.4M | $5.8M | $6.4M | — |
| Gross profit | $7.4M | $7.2M | $3.8M | $4.8M | — |
| Gross margin | 50.32% | 68.87% | 66.47% | 75.81% | — |
| Operating expenses | $16.9M | $69.3M | $5.7M | $3.6M | — |
| Operating income | −$9.6M | −$62.2M | −$1.9M | −$3.6M | — |
| Operating margin | −65.55% | −596.38% | −32.49% | −56.37% | — |
| EBITDA | −$7.0M | −$60.8M | −$1.9M | −$1.6M | — |
| EBITDA margin | −47.85% | −583.68% | −32.48% | −24.90% | — |
| Net income | −$14.7M | −$57.7M | −$3.8M | −$3.2M | — |
| Net profit margin | −100.65% | −553.69% | −65.26% | −50.84% | — |
| Basic EPSper basic share | -$0.73 | -$5.65 | -$0.95 | -$1.56 | $0.03 |
| Diluted EPSper diluted share | -$0.73 | -$5.65 | -$0.95 | -$1.56 | $0.03 |
Reported shareholders
| Holder | % owned |
|---|---|
ARMISTICE CAPITAL, LLC | 7.33%4.08M shares |
Aisiku Imoigele | ≈6.37%3.55M shares |
WICKERSHAM DAVID L. | ≈2.13%1.19M shares |
JANE STREET GROUP, LLC | 1.41%785.32K shares |
Leonard Jerry | ≈1.28%710.94K shares |
VANGUARD FIDUCIARY TRUST CO | 0.64%354.3K shares |
HRT FINANCIAL LP | 0.57%317.92K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.38%213.72K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.37%207.08K shares |
XTX Topco Ltd | 0.23%129.16K shares |
METZGER SCOTT | ≈0.21%117.36K shares |
LOWDERMILK KEVIN | ≈0.20%108.73K shares |
O'SULLIVAN COLIN P. | ≈0.20%108.73K shares |
FAIRFAX CYDONII V. | ≈0.19%108.5K shares |
Virtu Financial LLC | 0.19%106K shares |
OSAIC HOLDINGS, INC. | 0.18%99.79K shares |
TWO SIGMA SECURITIES, LLC | 0.13%73.03K shares |
CITADEL ADVISORS LLC | 0.06%33.56K shares |
NORTHERN TRUST CORP | 0.05%27.37K shares |
STATE STREET CORP | 0.03%18.9K shares |
Percentages use 55.68M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.